Summary
Nuclea Biotechnologies Inc. (Nuclea) is a healthcare center that develops and commercializes clinical diagnostic assays identifying gene and protein expression profiles. The center develops IVD and RUO diagnostic assays and kits for the early detection and monitoring of biomarkers in oncology and endocrinology. It provides CLIA tests for proteins associated with cancer and other chronic diseases. Nuclea provides clia lab and biomarker services. It conducts research on molecular oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries. The center partners with various institutes, medical centers and medical universities. Nuclea is headquartered in Pittsfield, Massachusetts, the US.
Nuclea Biotechnologies Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Nuclea Biotechnologies Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Nuclea Biotechnologies Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 11
Venture Financing 12
Nuclea Biotechnologies Raises US$4.2 Million In Series D Financing 12
Nuclea Biotechnologies Raises US$1.1 Million In Venture Financing 13
Nuclea Biotechnologies Raises US$5 Million In Series C Financing 14
Nuclea Biotech Raises US$0.6 Million In Venture Financing 15
Nuclea Biotechnologies Raises US$1.9 Million in Venture Financing 16
Nuclea Biotechnologies Raises Additional US$1.4 Million In Series B Financing 17
Nuclea Biotechnologies Secures US$5.5 Million In Financing Round 18
Partnerships 19
Nuclea Biotech Enters into Joint Development Partnership with Aelan Cell Technologies 19
Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 20
Enzo Clinical Labs And Nuclea Biotech Enter Into Agreement To Market Breast Cancer Test 21
Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 22
Nuclea Biotech Enters Into Co-Development Agreement With Nuvera 23
Nuclea Biotech Enters Into Research Agreement With College of Nanoscale Science For Cancer Diagnosis 24
Nuclea Biotech Enters Into Research Agreement With Berkshire Medical Center For Cancer Biomarkers 25
Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 26
Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 27
Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 28
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 29
Nuclea Biotechnologies Enters Into Partnership With Boston Medical Center 30
Acquisition 31
Nuclea Biotechnologies Acquires Wilex 31
Nuclea Biotechnologies Inc. - Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Nuclea Biotechnologies Inc., Medical Equipment, Key Facts 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Nuclea Biotechnologies Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Nuclea Biotechnologies Inc., Deals By Market, 2010 to YTD 2016 8
Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 11
Nuclea Biotechnologies Raises US$4.2 Million In Series D Financing 12
Nuclea Biotechnologies Raises US$1.1 Million In Venture Financing 13
Nuclea Biotechnologies Raises US$5 Million In Series C Financing 14
Nuclea Biotech Raises US$0.6 Million In Venture Financing 15
Nuclea Biotechnologies Raises US$1.9 Million in Venture Financing 16
Nuclea Biotechnologies Raises Additional US$1.4 Million In Series B Financing 17
Nuclea Biotechnologies Secures US$5.5 Million In Financing Round 18
Nuclea Biotech Enters into Joint Development Partnership with Aelan Cell Technologies 19
Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 20
Enzo Clinical Labs And Nuclea Biotech Enter Into Agreement To Market Breast Cancer Test 21
Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 22
Nuclea Biotech Enters Into Co-Development Agreement With Nuvera 23
Nuclea Biotech Enters Into Research Agreement With College of Nanoscale Science For Cancer Diagnosis 24
Nuclea Biotech Enters Into Research Agreement With Berkshire Medical Center For Cancer Biomarkers 25
Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 26
Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 27
Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 28
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 29
Nuclea Biotechnologies Enters Into Partnership With Boston Medical Center 30
Nuclea Biotechnologies Acquires Wilex 31
Nuclea Biotechnologies Inc., Key Competitors 32
Nuclea Biotechnologies Inc., Key Employees 33
Nuclea Biotechnologies Inc., Other Locations 34
Nuclea Biotechnologies Inc., Subsidiaries 34
List of Figures
Nuclea Biotechnologies Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Nuclea Biotechnologies Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Nuclea Biotechnologies Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8
